Americans have plenty of reasons to be upset at Big Pharma. Medications that make it to the doctor’s script pad are often developed because US taxpayers have financed the research with government grants. Yet pharmaceutical companies somehow manage to obtain patent rights that should belong to the people who have paid for their development, the American people, and then stiff us at the prescription counter. Adding insult to injury those pharmaceutical companies then routinely sell their products to foreign nations for less than they charge us. The most notorious ‘skin game’ by pharmaceutical companies in recent years has to be the EpiPen story. Epinephrine (adrenaline) was first isolated in 1895 by Napoleon Cybulski, a Polish physiologist and a pioneer of endocrinology and electroencephalography (EEG). Among a number of contributions to modern medicine that Cybulski made was being the first to isolate and identify the substance which is often the only chance that the victim of a violent allergic reaction, known as anaphylaxis, has for survival. The hormone, which only costs a few dollars for a vial, is now used in hospitals around the world and is included on the World Health Organization’s list of essential medicines. The delivery device for epinephrine, now called the EpiPen, was developed by the US military in the 1970s as a device that could be easy to use in emergency situations to field treat soldiers in the event of chemical warfare.